0001104659-19-047348.txt : 20190826
0001104659-19-047348.hdr.sgml : 20190826
20190826213503
ACCESSION NUMBER: 0001104659-19-047348
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190821
FILED AS OF DATE: 20190826
DATE AS OF CHANGE: 20190826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sender Gary
CENTRAL INDEX KEY: 0001659085
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 191054154
MAIL ADDRESS:
STREET 1: C/O SYNERGY PHARMACEUTICALS INC.
STREET 2: 420 LEXINGTON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4/A
1
a4a.xml
4/A
X0306
4/A
2019-08-21
2019-08-21
0
0001641640
Nabriva Therapeutics plc
NBRV
0001659085
Sender Gary
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Chief Financial Officer
Ordinary Shares
2019-08-21
4
S
0
3390
2.08
D
19214
D
This amendment is being filed solely to correct the transaction code from "F" to "S" for the sale of ordinary shares to satisfy tax withholding obligations in connection with the transaction reported in the Form 4 filed by the reporting person on August 21, 2019.
/s/ Robert Crotty, by power of attorney
2019-08-26